Aurora Cannabis announced that its Special Committee will conduct a thorough review of Curaleaf's revised hostile takeover bid offering US$5.00 per share. Shareholders are advised to take no action until the Board provides a formal recommendation, expected before the bid's expiry on December 4, 2026. The review aims to ensure shareholders can make an informed decision on the offer's value. Aurora will communicate its recommendation and relevant details once the review is complete.
Aurora Cannabis shares trade at USD 4.59 on Pluang as of Oct 07, 2026 03:42 WIB, below the revised hostile bid price of USD 5.00 per share by Curaleaf. The stock is closer to its 52-week low of USD 2.58 than its high of USD 6.17, showing a wide range of investor sentiment. Despite a 3.03% gain in the last day, the majority of Pluang traders are selling, with 62% of order activity on the sell side, reflecting cautious positioning ahead of the Board's recommendation expected before December 4, 2026.
Aurora Cannabis responded to Curaleaf's announcement of a revised hostile takeover bid offering $5.00 per share, including cash and Curaleaf shares. Aurora's Special Committee will thoroughly review the formal revised offer before recommending action...
Curaleaf Holdings Inc. has increased its acquisition offer for Canadian cannabis producer Aurora Cannabis by 25%, raising the total value to $5 per Aurora share in a mix of cash and stock. This new offer represents an 86% premium over Aurora's averag...
Curaleaf Holdings has increased its offer to acquire Aurora Cannabis shares by 25%, raising the total consideration to US$5.00 per share, which includes US$1.00 in cash and 0.4013 Curaleaf shares. This offer represents an 86% premium over Aurora's un...
